Reports of Transvaginal Mesh Complications on the Rise
For years, transvaginal mesh—also known as a bladder sling—has been used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI) in women.
However, increasing reports of severe health complications related to this medical device induced a recent Food and Drug Administration (FDA) advisory and prompted numerous lawsuits against manufacturers of transvaginal mesh.
These surgical mesh devices are used in the treatment of POP, in which a woman’s uterus or bladder can slide out of place, and SUI, an involuntary release of urine that occurs primarily during physical activity. According to the FDA’s latest review, however, mounting evidence indicates that transvaginal mesh is potentially ineffective and may actually pose more risks than benefits.
Complications linked to transvaginal mesh devices include:
- Erosion of the material into the vagina
- Injury to surrounding organs
- Pelvic pain
- Urinary problems
- Vaginal pain
Allegations against the manufacturers of transvaginal mesh products include that companies failed to adequately research the devices, failed to warn about the risk of complications, and were negligent in the design of these products. Manufacturers of transvaginal mesh linked to health risks include:
- American Medical Systems (AMS)
- Boston Scientific
- C.R. Bard
- Johnson & Johnson
For more than 30 years, the Virginia attorneys at Kalfus & Nachman have helped the victims of defective products, including medical devices, recover the compensation they need. We have the experience and tenacity to hold negligent medical product companies accountable for their actions.